home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  August 25, 2019
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 521 active entries

Exiqon A/S

Bygstubben 9
Vedbæk DK-2950 , Denmark

Phone: (+45) 45 66 08 88
Fax: (+45) 45 66 18 88

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Exiqon is a Danish biotech company focused on the development of enabling technology platforms and novel DNA- and immuno-diagnostic products against common genetic diseases, in particular, cardio-vascular, diabetic and other chronic and degenerative diseases. In other fields Exiqon is a potential technology partner for licensees Exiqon's IPR includes LNA (Locked Nucleic Acids) and a universal method for the covalent coupling of diagnostic molecules to solid supports.

Selected Categories:

Product Company   Service Company
- General
- Research
- in vitro

Last update of this entry: September 23, 2008

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.